
Type 1 diabetes misunderstood as “disease of childhood”
pharmafile | December 1, 2017 | News story | Medical Communications | biotech, diabetes, drugs, pharma, pharmaceutical
New research published in The Lancet has revealed that type 1 diabetes cannot be understood as a “disease of the childhood” as 42% of those diagnosed with the condition were found to individuals over 30 years old.
The finding is particularly important because there are many cases of individuals being misdiagnosed as having type 2 diabetes, which can lead to the wrong medication being prescribed. This can cause hospitalisation in those living with type 1 diabetes, as improperly managed insulin levels can result in diabetic ketoacidosis – a potentially life threatening condition.
The reason misdiagnosis is a challenge for doctors is because type 1 diabetes is widely understood to be a disease likely to occur in childhood; the reality is that type 2 diabetes generally only presents itself later in life, whereupon the proportion of diagnosis of diabetes is 96% in favour of type 2.
This often leads to the natural conclusion that adult diagnosis of insulin issues are related to type 2 diabetes; the study found that 4% of all diagnosis of diabetes cases were actually type 1 and displayed clinical characteristics that differed from those with type 2.
During the course of the study, those with type 1 diabetes were more likely to have a lower BMI and were more likely to have experienced diabetic ketoacidosis.
Type 1 diabetes occurs in individuals due to the pancreas not producing sufficient levels of insulin, which is assumed to be caused by genetic and environmental risk factors.
By comparison, type 2 diabetes is more often diagnosed due to lifestyle factors, in combination with genetics factors and results in a resistance to insulin produced by the body, alongside lower levels produced.
The study concluded: “use of a novel genetic approach to define type 1 diabetes has shown that it presents across the first six decades of life and should not be considered a disease of children and young adults. Whatever age it presents, type 1 diabetes is associated with rapid requirement for insulin and risk of ketoacidosis, suggesting that it is not a milder phenotype if diagnosed later in life. A key area for both clinical practice and research in the future is to improve recognition of late-onset type 1 diabetes.”
Ben Hargreaves
Related Content

Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose …

Amphista doses first patient in AML trial of protein degrader
Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an …

First 90 days of antipsychotic treatment linked to rapid metabolic changes
The first 90 days after starting antipsychotic treatment are a critical period for monitoring blood …






